Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Clearwater Should Ready Tissue, Pulp Units for Sale, SAC Says

Aug. 17 (Bloomberg) -- Clearwater Paper Corp. should separate the company’s tissue and pulp units for a possible sale, SAC Capital Advisors LP, the hedge fund run by Steven Cohen, said.

Clearwater should separate the consumer products unit, which makes tissue, from the pulp and paperboard unit so that it can sell one or both of the businesses, Stamford, Connecticut-based SAC said today in a regulatory filing. SAC also proposed that Spokane, Washington-based Clearwater hire an investment bank to advise on divestitures and add two independent directors to the six-member board.

SAC told Clearwater’s board in a May 1 letter that the stock is “deeply undervalued,” partly because litigation and a tissue acquisition were causing uncertainty. Clearwater is worth $43 to $67 a share when the two businesses are evaluated separately, SAC said in the letter. SAC holds 1.64 million Clearwater shares representing 7.1 percent of outstanding stock, it said.

Matt Van Vleet, a Clearwater spokesman, didn’t immediately return a phone message seeking comment after regular business hours.

Clearwater rose 0.4 percent to $36.66 at the close in New York.

To contact the reporter on this story: Jack Kaskey in Houston at

To contact the editor responsible for this story: Simon Casey at

Please upgrade your Browser

Your browser is out-of-date. Please download one of these excellent browsers:

Chrome, Firefox, Safari, Opera or Internet Explorer.